IBS Symptoms: How to Tell If You Have IBS vs Something Else
At a Glance
- IBS affects 10-15% of the global population, with only 30% seeking medical care
- The Rome IV criteria define IBS as recurrent abdominal pain related to defecation, with altered stool form or frequency
- IBS is subtyped as IBS-D (diarrhea), IBS-C (constipation), IBS-M (mixed), or IBS-U (unsubtyped)
- Red flag symptoms (blood in stool, weight loss, nighttime symptoms, onset after 50) require investigation to rule out organic disease
- Diagnosis is primarily clinical; extensive testing is not needed when Rome IV criteria are met without red flags
What IBS Is (and Is Not)
Irritable bowel syndrome is a functional gastrointestinal disorder, now classified as a disorder of gut-brain interaction. There is no structural abnormality, no inflammation visible on biopsy (unlike IBD), and no lab test that confirms it [1].
This does not mean IBS is not real. The symptoms are caused by measurable physiological abnormalities: visceral hypersensitivity (the gut nerves overreact to normal stimuli), altered motility (too fast in IBS-D, too slow in IBS-C), gut microbiome dysbiosis, impaired intestinal permeability, and dysregulated communication between the gut and brain via the vagus nerve and enteric nervous system [2].
The Core Symptoms
Abdominal Pain
The defining symptom of IBS. Rome IV criteria require recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, with onset at least 6 months prior to diagnosis. The pain must be associated with at least two of the following [3]:
- Related to defecation (improves or worsens with bowel movements)
- Associated with a change in stool frequency
- Associated with a change in stool form (appearance)
IBS pain is typically:
- Crampy or colicky in character
- Located in the lower abdomen (left lower quadrant most common, but can be diffuse)
- Variable in intensity from day to day
- Worse after eating (postprandial exacerbation from the gastrocolic reflex)
- Often improved by passing gas or having a bowel movement
- Absent during sleep (nocturnal pain that wakes you suggests organic disease, not IBS)
Altered Bowel Habits
IBS is subtyped by the predominant stool pattern using the Bristol Stool Scale:
| Subtype | Pattern | Bristol Types | Prevalence |
|---|---|---|---|
| IBS-D (diarrhea) | Frequent loose/watery stools, urgency | Types 6-7 | ~33% |
| IBS-C (constipation) | Infrequent, hard, difficult-to-pass stools | Types 1-2 | ~33% |
| IBS-M (mixed) | Alternating between diarrhea and constipation | Both extremes | ~33% |
| IBS-U (unsubtyped) | Does not fit clearly into above categories | Variable | Uncommon |
Subtyping matters for treatment selection. It can also shift over time: some patients transition between subtypes over months or years.
Bloating and Distension
Bloating is reported by 75-90% of IBS patients and is often rated as the most bothersome symptom, even above pain [4]. Bloating refers to the subjective sensation of abdominal fullness or pressure. Distension is the objective, measurable increase in abdominal girth.
Interestingly, studies using abdominal CT and gas infusion show that IBS patients do not produce more gas than healthy controls. Instead, their abdominal muscles respond abnormally: the diaphragm descends and the anterior abdominal wall relaxes, causing visible distension in response to normal gas volumes. This is a motor response mediated by altered gut-brain communication, not an excess gas problem.
Urgency
The sudden, intense need to find a bathroom, with anxiety about not making it in time. Most common in IBS-D but can occur in IBS-M during diarrhea phases. Urgency drives significant behavioral changes: knowing bathroom locations, avoiding travel, and meal timing around bathroom access.
Incomplete Evacuation
The sensation that the bowel has not fully emptied after a movement. Common in IBS-C and sometimes leads to excessive straining and multiple bathroom trips. When persistent, it should be evaluated for pelvic floor dysfunction (dyssynergic defecation), which coexists with IBS in approximately 30% of patients [5].
Mucus in Stool
Passage of clear or white mucus with bowel movements occurs in some IBS patients. Small amounts of mucus are normal. Excessive mucus without blood is consistent with IBS. Bloody mucus is a red flag requiring further workup.
Associated Symptoms Beyond the Gut
IBS frequently co-occurs with non-GI symptoms, reflecting the systemic nature of gut-brain dysfunction:
- Fatigue: Reported by 50-60% of IBS patients. Correlates with symptom severity and sleep disruption.
- Back pain: Referred pain from the gut or associated musculoskeletal tension.
- Urinary symptoms: Urgency, frequency, and nocturia overlap with IBS, possibly due to shared pelvic nerve pathways.
- Fibromyalgia: Coexists in 30-70% of IBS patients. Both conditions involve central sensitization.
- Anxiety and depression: Present in 40-60% of IBS patients. The gut-brain axis is bidirectional: anxiety worsens IBS, and IBS worsens anxiety [6].
- Migraine: IBS patients have 2-3x higher migraine prevalence than the general population.
Red Flags: When It Might Not Be IBS
These symptoms are NOT typical of IBS and should prompt investigation for organic disease:
- Rectal bleeding or blood in stool: Suggests IBD, colorectal cancer, or hemorrhoids (but hemorrhoids warrant confirmation)
- Unintentional weight loss: More than 5% body weight over 6 months without trying
- Nocturnal symptoms: Pain or diarrhea that wakes you from sleep (IBS symptoms typically occur during waking hours)
- Onset after age 50: New GI symptoms after 50 need colorectal cancer screening before attributing to IBS
- Family history of colon cancer, IBD, or celiac disease: Lowers the threshold for testing
- Fever: Not a feature of IBS
- Progressive worsening: IBS symptoms fluctuate but do not progressively worsen over months. Steady decline suggests organic pathology.
- Anemia on bloodwork: Suggests malabsorption (celiac disease) or chronic blood loss
Conditions That Mimic IBS
| Condition | How It Differs from IBS | Key Test |
|---|---|---|
| Celiac disease | Malabsorption (weight loss, anemia, nutritional deficiencies), can look identical to IBS-D | tTG-IgA antibody; duodenal biopsy |
| Inflammatory bowel disease | Blood in stool, weight loss, elevated inflammatory markers, nocturnal symptoms | Fecal calprotectin; colonoscopy |
| Microscopic colitis | Chronic watery diarrhea without visible mucosal abnormality on colonoscopy | Colonic biopsies (random) |
| SIBO | Bloating and diarrhea that worsen with certain carbohydrates; may overlap with IBS | Lactulose or glucose breath test |
| Bile acid malabsorption | Watery diarrhea, especially after meals; commonly missed cause of IBS-D | SeHCAT scan or empiric cholestyramine trial |
| Lactose/fructose intolerance | Symptoms correlate specifically with dairy or fructose intake | Hydrogen breath test; elimination trial |
| Endometriosis | GI symptoms cyclical with menstruation; pelvic pain | Clinical assessment; laparoscopy |
| Colorectal cancer | Progressive symptoms, rectal bleeding, weight loss, change in stool caliber after age 50 | Colonoscopy |
What Testing Is Actually Needed
When Rome IV criteria are met and no red flags are present, IBS can be diagnosed clinically without extensive testing. The American College of Gastroenterology recommends [7]:
- For all suspected IBS: CBC, CRP or ESR, celiac panel (tTG-IgA). If all normal and no red flags, no further testing is needed.
- For IBS-D specifically: Add fecal calprotectin (to exclude IBD) and consider bile acid malabsorption testing.
- Colonoscopy is NOT required for typical IBS in patients under 45 without red flags. Over 45, colonoscopy is recommended for age-appropriate cancer screening regardless of IBS.
Overtesting is a common problem in IBS care. Repeated normal test results do not provide reassurance; they often increase health anxiety. A confident positive diagnosis (“you have IBS”) is more therapeutic than a tentative diagnosis of exclusion [8].
Post-Infectious IBS
6-17% of people who recover from acute gastroenteritis develop IBS symptoms that persist for months to years. This is called post-infectious IBS (PI-IBS). Risk factors include severity of the initial infection, female sex, younger age, and pre-existing anxiety or depression [9].
The mechanism involves persistent low-grade inflammation, altered gut permeability, and microbiome disruption that outlasts the infection itself. PI-IBS tends to be IBS-D predominant and has a somewhat better prognosis than non-PI-IBS, with gradual improvement over years in many patients.
When to See a Gastroenterologist
- Symptoms persist despite 4-6 weeks of dietary modification
- Any red flag symptoms are present
- You are over 45 and have not had a colonoscopy
- Symptoms significantly impair daily function, work, or quality of life
- You need guidance on the low FODMAP diet or medication options
Related Reading
- Irritable Bowel Syndrome: The Evidence-Based Guide (Pillar)
- IBS Diet: What to Eat, FODMAP Basics, and Meal Planning
References
- Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.e5. doi:10.1053/j.gastro.2016.02.031
- Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016;2:16014. doi:10.1038/nrdp.2016.14
- Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407. doi:10.1053/j.gastro.2016.02.031
- Houghton LA, Lea R, Agrawal A, et al. Relationship of abdominal bloating to distension in irritable bowel syndrome and effect of bowel habit. Gastroenterology. 2006;131(4):1003-1010. doi:10.1053/j.gastro.2006.07.015
- Rao SS, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430-1442.e4. doi:10.1053/j.gastro.2016.02.009
- Koloski NA, Jones M, Kalantar J, et al. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284-1290. doi:10.1136/gutjnl-2011-300474
- Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036
- Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-958. doi:10.1001/jama.2015.0954
- Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152(5):1042-1054.e1. doi:10.1053/j.gastro.2016.12.039
